Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F George

Showing results (691-700 of 750) with videos related to

Pageof 75
Sort By:
Journal of Medicinal Chemistry|January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitorsKevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymeraseKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Journal of Medicinal Chemistry|April 28, 2006
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replicationStéphane L Bogen, Ashok Arasappan, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitorQingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2012
Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitorsVishal A Verma, Randall Rossman, Frank Bennett, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 20, 2022
First clinical-grade porcine kidney xenotransplant using a human decedent modelPaige M Porrett, Babak J Orandi, Vineeta Kumar, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2022
A Comprehensive Immune Cell Atlas of Cystic Kidney Disease Reveals the Involvement of Adaptive Immune Cells in Injury-Mediated Cyst Progression in MiceCheng J Song, Zhang Li, Ummey Khalecha Bintha Ahmed, et al.
Diabetes|January 17, 2008
A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association studyHakon Hakonarson, Hui-Qi Qu, Jonathan P Bradfield, et al.
Journal of Synchrotron Radiation|April 19, 2008
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034Vincent Madison, Andrew J Prongay, Zhuyan Guo, et al.
Pageof 75

Showing results (691-700 of 750) with videos related to

Sort By:
Pageof 75
Journal of Medicinal Chemistry|January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitorsKevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymeraseKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Journal of Medicinal Chemistry|April 28, 2006
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replicationStéphane L Bogen, Ashok Arasappan, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitorQingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2012
Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitorsVishal A Verma, Randall Rossman, Frank Bennett, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 20, 2022
First clinical-grade porcine kidney xenotransplant using a human decedent modelPaige M Porrett, Babak J Orandi, Vineeta Kumar, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2022
A Comprehensive Immune Cell Atlas of Cystic Kidney Disease Reveals the Involvement of Adaptive Immune Cells in Injury-Mediated Cyst Progression in MiceCheng J Song, Zhang Li, Ummey Khalecha Bintha Ahmed, et al.
Diabetes|January 17, 2008
A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association studyHakon Hakonarson, Hui-Qi Qu, Jonathan P Bradfield, et al.
Journal of Synchrotron Radiation|April 19, 2008
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034Vincent Madison, Andrew J Prongay, Zhuyan Guo, et al.
Pageof 75